Терапевтический архив (Jan 2025)
New pathogenic mutation in LMNA gene: Clinical case of familial cardiomyopathy
- Svetlana Y. Kashtanova,
- Elena М. Rimskaya,
- Aleksei N. Meshkov,
- Nataliia А. Mironova,
- Irina K. Dzhumaniiazova,
- Elena A. Zelenova,
- Veronika V. Daniel',
- Mikhail V. Ivanov,
- Daria A. Kashtanova,
- Vladimir S. Yudin,
- Anton A. Keskinov,
- Sergey I. Mitrofanov,
- Alexsandra I. Akinshina,
- Yulia N. Vanyushina,
- Sergey А. Kraevoy,
- Sergey M. Yudin,
- Sergey P. Golitsyn
Affiliations
- Svetlana Y. Kashtanova
- ORCiD
- Chazov National Medical Research Center of Cardiology
- Elena М. Rimskaya
- ORCiD
- Chazov National Medical Research Center of Cardiology
- Aleksei N. Meshkov
- ORCiD
- Chazov National Medical Research Center of Cardiology
- Nataliia А. Mironova
- ORCiD
- Chazov National Medical Research Center of Cardiology
- Irina K. Dzhumaniiazova
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Elena A. Zelenova
- Center for Strategic Planning and Management of Biomedical Health Risks
- Veronika V. Daniel'
- ORCiD
- Chazov National Medical Research Center of Cardiology
- Mikhail V. Ivanov
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Daria A. Kashtanova
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Vladimir S. Yudin
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Anton A. Keskinov
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Sergey I. Mitrofanov
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Alexsandra I. Akinshina
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Yulia N. Vanyushina
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Sergey А. Kraevoy
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Sergey M. Yudin
- ORCiD
- Center for Strategic Planning and Management of Biomedical Health Risks
- Sergey P. Golitsyn
- ORCiD
- Chazov National Medical Research Center of Cardiology
- DOI
- https://doi.org/10.26442/00403660.2025.01.203030
- Journal volume & issue
-
Vol. 97,
no. 1
pp. 65 – 70
Abstract
We present a clinical case of familial LMNA-associated cardiomyopathy, confirmed by whole genome sequencing. The typical for lamin-associated cardiomyopathy indicates pathogenic nature of the mutation in the first exon of LMNA gene, previously considered a mutation of unknown clinical significance. The presented clinical case demonstrates a radical change in patient treatment strategies in the context of the widespread introduction of molecular genetic research methods into practice.
Keywords
- cardiomyopathy
- laminopathy
- genome-wide sequencing
- sudden cardiac death
- heart failure
- atrioventricular block